Objective

This study aimed to determine whether there are regional differences in the blood-brain barrier (BBB) permeability of cognitively normal elderly participants and to identify factors influencing BBB permeability with a clinically feasible, 10-minute dynamic contrast-enhanced (DCE) MRI protocol.

Materials and Methods

This IRB-approved prospective study recruited 35 cognitively normal adults (26 women; mean age, 64.5±5.6 years) who underwent DCE T1-weighted imaging. Permeability maps (K trans) were coregistered with masks to calculate the mean regional values. The paired t test and Friedman test were used to compare Ktrans between different regions. The relationships between K trans and the factors of age, sex, education, cognition score, vascular risk burden, vascular factors on imaging, and medial temporal lobar atrophy were assessed using Pearson correlation and the Spearman rank test.

Results

The mean permeability rates of the right and left hippocampi, as assessed with automatic segmentation, were 0.529±0.472 and 0.585±0.515 (K trans,× 10− 3 min− 1), respectively. Concerning the deep gray matter, the K trans of the thalamus was significantly greater than those of the putamen and hippocampus (p= 0.007, p= 0.041). Regarding the white matter, the K trans value of the occipital white matter was significantly greater than those of the frontal, cingulate, and temporal white matter (p< 0.0001, p= 0.0007, p= 0.0002). The variations in K trans across brain regions were not related to age, cognitive score, vascular risk burden, vascular risk factors on imaging, or medial temporal lobar atrophy in the study group.

Conclusion

Our study demonstrated regional differences in BBB permeability (K trans) in cognitively normal elderly adults using a clinically acceptable 10-minutes DCE imaging protocol. The regional differences suggest that the integrity of the BBB varies across the brains of cognitively normal elderly adults. We recommend considering regional differences in K trans values when evaluating BBB permeability in patients with neurodegenerative diseases.